dkk 1,419.00 <%= Resources.Global.txtUp %>
Updated 08:37:31
Change % 0.35% Stock price increasing
Change 5.00 Stock price increasing
Volume 19,199
High DKK 1,419.00
Low DKK 1,406.00
Open DKK 1,411.00
ISIN DK0010272202
Prev close DKK 1,414.00
# of shares 61.12M
Market cap 86,727M DKK
Intraday

Genmab A/S
Market is open (until 16:00) - Delayed 15 min
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  1,419.00 0.2% Stock price increasing 6.0% Stock price increasing -3.9% Stock price decreasing 1.7% Stock price increasing 23.8% Stock price increasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
1,133
730
764
3,487
3,903
2014
850
265
301
2,032
2,866
2013
664
69
112
660
1,732
2012
485
-117
-487
383
1,693
2011
351
-249
-596
486
1,564
2010
582
-161
-321
1,080
2,482
2009
586
0
-1,011
1,297
2,222
2008
745
-870
-965
2,189
0
2007
530
-437
-383
2,883
0
Powered by TradingView

News about Genmab A/S

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Eisai CO Ltd 43.20 -1.0% Stock price decreasing 1.6% Stock price increasing 41.6% Stock price increasing 41.6% Stock price increasing 41.6% Stock price increasing 41.6% Stock price increasing
 
Bristol-Myers Squibb Company 63.33 1.4% Stock price increasing 9.8% Stock price increasing 10.5% Stock price increasing 12.4% Stock price increasing 12.2% Stock price increasing 8.4% Stock price increasing
 
Johnson & Johnson 131.75 -2.0% Stock price decreasing -2.2% Stock price decreasing -3.2% Stock price decreasing 4.3% Stock price increasing 10.3% Stock price increasing 14.4% Stock price increasing
 
Pfizer Inc 35.97 1.7% Stock price increasing 8.5% Stock price increasing 5.6% Stock price increasing 4.4% Stock price increasing 5.3% Stock price increasing 10.7% Stock price increasing
 
Amgen Inc 186.64 -0.4% Stock price decreasing 9.7% Stock price increasing 7.4% Stock price increasing 11.5% Stock price increasing 6.3% Stock price increasing 27.7% Stock price increasing
 
Bavarian Nordic A/S 251.50 9.3% Stock price increasing -39.8% Stock price decreasing -35.5% Stock price decreasing -27.2% Stock price decreasing -5.5% Stock price decreasing 1.0% Stock price increasing
 
Merck Kgaa O.N. 96.13 -0.8% Stock price decreasing 4.2% Stock price increasing -13.9% Stock price decreasing -5.3% Stock price decreasing -1.7% Stock price decreasing -3.0% Stock price decreasing
 
Novartis NAM SF 0,50 71.41 -0.4% Stock price decreasing 0.5% Stock price increasing -7.6% Stock price decreasing 3.9% Stock price increasing -2.1% Stock price decreasing 3.4% Stock price increasing
 
Roche Hldg AG GEN 214.40 1.1% Stock price increasing 0.3% Stock price increasing -7.6% Stock price decreasing -8.3% Stock price decreasing -5.0% Stock price decreasing -0.8% Stock price decreasing
 
Biogen Inc 315.03 -1.9% Stock price decreasing 9.9% Stock price increasing 12.3% Stock price increasing 13.4% Stock price increasing 0.1% Stock price increasing 11.1% Stock price increasing
 
Emergent Biosolutions Inc 37.65 -1.1% Stock price decreasing 5.0% Stock price increasing 10.9% Stock price increasing 28.2% Stock price increasing 31.0% Stock price increasing 14.6% Stock price increasing
 
Bayer AG NA O.N. 110.30 0.0% Stock price increasing 1.3% Stock price increasing -10.0% Stock price decreasing 5.0% Stock price increasing 19.6% Stock price increasing 11.3% Stock price increasing
Indices Open
 
OMX Copenhagen 20 CAP 1,169.07 1.4% Stock price increasing 0.2% Stock price increasing -0.1% Stock price decreasing 10.4% Stock price increasing 11.8% Stock price increasing 14.7% Stock price increasing

Company profile

Genmab is a leading international biotechnology company located in Denmark. They focus on developing medication for cancer treatments. Genmab uses advanced technology to create and develop products to address unmet medical needs.

Peers

Indices Last Change  
OMX C20 Cap 1,169.07 -0.1% Stock price decreasing
100,22,67,75,51,20,20,13,38,50
Instruments Last Change  
Eisai CO Ltd 43.20 0.7% Stock price increasing
0,0,0,0,0,0,0,0,0,0
Bristol-Myer.. 63.33 0.0% Stock price unchanged
Johnson & Jo.. 131.75 0.0% Stock price unchanged
Pfizer Inc 35.97 0.0% Stock price unchanged
Amgen Inc 186.64 0.0% Stock price unchanged
100,59,69,52,40,33,18,24,33,0
Bavarian Nor.. 251.50 0.4% Stock price increasing
77,55,33,11,11,33,44,33,44,44
Merck Kgaa O.. 96.13 -0.3% Stock price decreasing
Novartis NAM.. 71.41 -0.1% Stock price decreasing
Roche Hldg A.. 214.40 -0.4% Stock price decreasing
Biogen Inc 315.03 0.0% Stock price unchanged
84,80,90,94,69,73,48,19,46,5
Emergent Bio.. 37.65 0.0% Stock price unchanged
Bayer AG NA .. 110.30 -0.1% Stock price decreasing

Targets for: Genmab A/S

Ritzau Finans
 
Analyst
Target
Date
Genmab/Citi: Kursmålet bliver løftet til 1800 kr. - citat
Citigroup
1,800 op
01/06/17
Genmab/JPMorgan: Hæver kursmål til 1500 kr.
JPMorgan
1,500 op
23/02/17
Genmab/Goldman: Kursmålet hæves til 1370 kr.
Goldman Sachs
1,370
17/01/17

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 September 2017 08:53:00
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170921.1 - EUROWEB3 - 2017-09-22 09:53:00 - 2017-09-22 08:53:00 - 1000 - Website: OKAY